Humira recommended for AS in Europe
The Associated Press reports that the anti-TNF drug Humira (adalimumab) has been recommended for approval in Europe for the treatment of severe and active ankylosing spondylitis by the scientific committee of the European Medicines Agency. A decision on approval is expected within 60 days.
See previous entries: Adalimumab (Humira) and ankylosing spondylitis; More about adalimumab.
Update, 4/29: AFX News in Forbes.
Comments on this post
My Rheumy just mentioned this medication to me as a potential option for my AS, although it's not approved here yet, as I just lost my access to Enbrel. :( Does anyone know what the status of FDA approval is of Humira for AS in the states?
Posted by
Boulder Chick (5/10/2006 9:34 PM)
Post a Comment
Links to this post
Create a Link